Cargando…
Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
In the summer of 2020, it became clear that the genetic composition of SARS-CoV-2 was changing rapidly. This was highlighted by the rapid emergence of the D614G mutation at that time. In the autumn of 2020, the project entitled “Agility” was initiated with funding from the Coalition for Epidemic Pre...
Autores principales: | Coombes, Naomi S., Bewley, Kevin R., Le Duff, Yann, Hurley, Matthew, Smith, Lauren J., Weldon, Thomas M., Osman, Karen, Pullan, Steven, Berry, Neil, Hallis, Bassam, Charlton, Sue, Hall, Yper, Funnell, Simon G. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056478/ https://www.ncbi.nlm.nih.gov/pubmed/36992342 http://dx.doi.org/10.3390/v15030633 |
Ejemplares similares
-
Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
por: Zhang, Meng, et al.
Publicado: (2022) -
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
por: Cantoni, Diego, et al.
Publicado: (2022) -
Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
por: Ryan, Kathryn A., et al.
Publicado: (2023) -
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
por: Supasa, Piyada, et al.
Publicado: (2021) -
The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection
por: Davies, Elizabeth R., et al.
Publicado: (2023)